bizalimogene ralaplasmid (VGX-3100) / Inovio, ApolloBio  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
bizalimogene ralaplasmid (VGX-3100) / Inovio
NCT00685412: Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3

Completed
1
18
US
VGX-3100
Inovio Pharmaceuticals
Papillomavirus Infections
01/11
03/11
NCT01188850: Fourth Dose of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + EP in Adult Females Previously Vaccinated With Three Doses of VGX-3100

Completed
1
14
US
VGX-3100
Inovio Pharmaceuticals
Human Papillomavirus (HPV)
10/11
10/11

Download Options